Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adma Biologics (ADMA) Shares Outstanding: 2011-2025

Historic Shares Outstanding for Adma Biologics (ADMA) over the last 12 years, with Sep 2025 value amounting to $239.7 million.

  • Adma Biologics' Shares Outstanding rose 1.39% to $239.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.7 million, marking a year-over-year increase of 1.39%. This contributed to the annual value of $236.6 million for FY2024, which is 4.67% up from last year.
  • Adma Biologics' Shares Outstanding amounted to $239.7 million in Q3 2025, which was up 0.12% from $239.4 million recorded in Q2 2025.
  • Adma Biologics' Shares Outstanding's 5-year high stood at $239.7 million during Q3 2025, with a 5-year trough of $123.0 million in Q1 2021.
  • In the last 3 years, Adma Biologics' Shares Outstanding had a median value of $233.0 million in 2024 and averaged $232.2 million.
  • Data for Adma Biologics' Shares Outstanding shows a peak YoY skyrocketed of 86.66% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Adma Biologics' Shares Outstanding stood at $195.8 million in 2021, then rose by 13.28% to $221.8 million in 2022, then climbed by 1.91% to $226.1 million in 2023, then climbed by 4.67% to $236.6 million in 2024, then climbed by 1.39% to $239.7 million in 2025.
  • Its last three reported values are $239.7 million in Q3 2025, $239.4 million for Q2 2025, and $238.5 million during Q1 2025.